A mechanistic model of erythroblast growth inhibition providing a framework for optimisation of cell therapy manufacturing (2018)
Attributed to:
Engineering Biological Science - Processes and Systems for Haematopoietic Stem Cell Based Therapy Manufacture
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.bej.2018.01.033
Publication URI: http://dx.doi.org/10.1016/j.bej.2018.01.033
Type: Journal Article/Review
Parent Publication: Biochemical Engineering Journal